2017-08-15T02:35:17-05:00 2016-12-31 521511275 Raffa PC 1899 L Street NW Suite 850 Washington DC 20036 990 2016-01-01 453083156 The Children's Oncology Group Foundation Inc CHIL 2155906359 3501 Civic Center Blvd CTRB 10060 Philadelphia PA 19104 Peter C Adamson MD President & Director 2155906359 2017-08-15 1 Frank H Smith P00639053 2028225000 2017-08-14 207.238.152.31 2017-08-15 03:35:03 ED P C3E152F0C85DEA7593A5B7F47976F855CC6874F7 F135C83ED9FEE547B936C2DB6A419AD746D8269C 2016 2021-01-29 14:40:06Z Peter C Adamson MD 3501 Civic Center Blvd CTRB 10060 Philadelphia PA 19104 9662660 0 X www.cog-foundation.org X 2011 PA A foundation devoted exclusively to childhood and adolescent cancer research. 6 6 0 10 0 0 9927823 8847315 107430 557777 1095 5010 0 0 10036348 9410102 6965777 7206460 0 0 0 0 0 0 26139 973506 1101182 7939283 8307642 2097065 1102460 16241983 17277501 284224 217831 15957759 17059670 X The Children's Oncology Group Foundation (the Foundation), helps support the research of the Children's Oncology Group (COG), which is the world's largest organization devoted exclusively to childhood and adolescent cancer research. 0 0 8265078 7206460 557777 The Children's Oncology Group Foundation enables COG's leadership, comprised of a team of doctors, nurses, laboratory scientists and other allied professionals, the ability to direct the resources raised for childhood cancer research to the areas of highest need and opportunity. The Foundation allows philanthropic funds from individual supporters and organizations to go directly to COG to fund its much needed research. In an era of rapid scientific discovery, this direct link allows COG researchers to respond quickly to new discoveries with the greatest potential to benefit children with cancer.The Children's Oncology Group has over 50 active clinical trials open at any given time. These trials include front-line treatment for many types of childhood cancers, studies aimed at determining the underlying biology of these diseases, and trials involving new and emerging treatments, supportive care, and survivorship. The Children's Oncology Group research has turned children's cancer from a virtually incurable disease 50 years ago to one with a combined 5-year survival rate of 80% today. Our goal is to cure all children and adolescents with cancer, reduce the short and long-term complications of cancer treatments, and determine the causes and find ways to prevent childhood cancer.Project:EveryChild: Children's Oncology Group's Project:EveryChild is our ambitious initiative to find better cures for every type of childhood cancer, no matter how rare. All children with cancer cared for at COG's more than 200 pediatric cancer programs will be able to participate in Project:EveryChild. 8265078 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 0 0 0 0 0 0 0 0 0 0 0 X 6 6 0 0 0 0 1 1 1 1 0 0 0 1 1 1 1 0 0 0 0 0 PA X X Peter C Adamson 2155906359 3501 Civic Center Blvd CTRB 10060 Philadelphia PA 19104 X Peter C Adamson MD President & Director 2.00 X X 0 0 0 Joseph Neglia MD MPH Secretary 0.50 X X 0 0 0 Naomi Winick MD Treasurer 0.50 X X 0 0 0 Carola Arndt MD Director (until 09/2016) 0.50 X 0 0 0 M Brooke Bernhardt PharmD MS BCOP Director 0.50 X 0 0 0 Susan M Blaney MD Director 0.50 X 0 0 0 Vikramjit Singh Kanwar MBBS Director 0.50 X 0 0 0 John Perentesis MD Director (until 09/2016) 0.50 X 0 0 0 0 0 0 0 0 0 0 Dilts Partners LLC 5317 Corinthian Bay Drive Plano TX 75093 Consulting services 224726 Public Health Institute 555 12th Street 10th Floor Oakland CA 94607 Research services 135290 2 8847315 8847315 Program service rev. 900099 557777 557777 557777 4476 4476 253092 252558 534 534 534 9410102 557777 0 5010 X 6674460 6674460 532000 532000 32563 32563 993662 861515 132147 4688 655 3397 636 44756 42642 2114 11937 11937 11451 11451 691 691 1184 1184 State registration fee 250 250 Indirect cost alloc. 0 130418 -155921 25503 8307642 8265078 16425 26139 585834 131123 5087504 9414633 9717798 7026027 846870 449340 2072 1036 1727 1036 253092 2250 2250 16241983 17277501 66771 62237 192570 155594 24883 0 284224 217831 X 674258 1937430 15283501 15122240 15957759 17059670 16241983 17277501 1102460 -549 0 X 0 1 X 0 0 X 13390695 9595377 10204963 9927823 8847315 51966173 13390695 9595377 10204963 9927823 8847315 51966173 52360 51913813 662 3616 579 1095 4476 10428 25 2577 2602 51979203 757484 0.99870 X Schedule A, Part II, Line 10, Explanation of Other Income: Miscellaneous income - 2012 Amount: $ 25. Fundraising sales - 2013 Amount: $ 2,577. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2072 1036 1036 1036 X 9446667 -549 37114 36565 9410102 0 9410102 8344756 37114 37114 8307642 0 8307642 Part X, Line 2: The Foundation accounts for uncertainty in income taxes recognized in the financial statements using a recognition threshold of more likely than not as to whether the uncertainty will be sustained upon examination by the appropriate taxing authority. 1 East Asia and the Pacific - Australia, Brunei, Burma, Cambodia, 0 0 Grantmaking 153000 North America - Canada and Mexico, but not the United States 0 0 Grantmaking 331000 Europe (Including Iceland & Greenland) - Albania, Andorra, Austria, Belgium 0 0 Grantmaking 47000 Middle East and North Africa - Algeria, Bahrain, Djibouti, Egypt, 0 0 Grantmaking 1000 0 0 0 0 0 0 532000 0 532000 East Asia and the Pacific - Australia, Brunei, Burma, Cambodia, To cure children and improve capacity of quality and treatment 153000 Check North America - Canada and Mexico, but not the United States To cure children and improve capacity of quality and treatment 331000 Check Europe (Including Iceland & Greenland) - Albania, Andorra, Austria, Belgium To cure children and improve capacity of quality and treatment 47000 Check 1 0 0 0 0 0 0 0 Part I, Line 2: The Foundation receives a full accounting of grantee expenditures on at least an annual basis, and requires grantee organizations to retain all financial records, supporting documents, research data and other pertinent records for at least three years following the date of submission of a final expenditure report. In addition, the Foundation cross-references grantee organizations with the Office of Foreign Assets Control's Specificially Designated Nationals and Blocked Persons List. Part I, line 3: In accordance with IRS instructions, all amounts reported in Parts I and II of Schedule F are reported using the accrual basis of accounting, the same method of accounting used in the financial statements. 1 Children's Hospital of Philadelphia - Research Institute 3615 Civic Center Boulevard Philadelphia PA 19104 231352166 501(c)(3) 5158900 Per-Case Reimbursement, Project:EveryChild. The Research Institute at Nationwide Children's Hospital 700 Childrens Drive Columbus OH 43205 316056230 501(c)(3) 1256060 Project:EveryChild, Reference Labs. University of Florida 219 Grinter Hall Box 115500 Gainesville FL 32611 592729133 501(c)(3) 37500 To cure children and improve capacity of quality and treatments. University of Chicago 6030 S Ellis Avenue Chicago IL 60637 366056201 501(c)(3) 72000 To cure children and improve capacity of quality and treatments. Arkansas Children's Research Institute 1 Childrens Way Little Rock AK 72202 710694931 501(c)(3) 150000 To cure children and improve capacity of quality and treatments. 5 0 Part I, Line 2: The Foundation receives a full accounting of grantee expenditures on at least an annual basis, and requires grantee organizations to retain all financial records, supporting documents, research data and other pertinent records for at least three years following the date of submission of a final expenditure report. Form 990, Part VI, Section A, line 6 The members shall consist of the voting members of the Executive Committee of The Children's Oncology Group. Form 990, Part VI, Section A, line 7a Each Member shall be entitled to one vote on each matter presented to the Members. Form 990, Part VI, Section A, line 7b The Members shall have the following exclusive powers: (a) Adopt and amend Statements of mission, philosophy or purpose; (b) Amend the the Foundation's Articles of Incorporation and ByLaws; (c) Elect and remove, with or without cause, the Directors of the Foundation's. Form 990, Part VI, Section A, line 8b The Foundation does not have the institutional capacity for such a process to occur, so the Board of Directors function on their own without a secondary committee. Form 990, Part VI, Section B, line 11b Under the direction of the Board of Director's President, the Foundation circulates the draft version of the federal Form 990 for Board of Directors' review by email correspondence, and then formally at our semi-annual meeting prior to filing with the Internal Revenue Service. Form 990, Part VI, Section B, line 12c The Conflict of Interest Policy is reviewed regularly at the Foundation's Board Meetings. During the interim of a meeting, conference calls and email communications are utilized for any incidental concerns. In connection with any actual or possible conflict of interest, an interested person must disclose the existence of the financial interest and disclose all material facts to the Directors considering the proposed transaction or arrangement. After disclosure of the financial interest and all material facts, and after any presentation by the interested person, the interested person shall leave the Board of Directors meeting while the determination of a conflict of interest is discussed and voted upon. The remaining Directors shall decide if a conflict of interest exists. Form 990, Part VI, Section C, line 19 The Foundation posts the federal Form 990, COI policy, and other governing documents on its website: http://cog-foundation.org/documents.php. Form 990, Part IX, line 11g Consulting fees: Program service expenses 586,554. Management and general expenses 132,147. Fundraising expenses 0. Total expenses 718,701. Research: Program service expenses 274,961. Management and general expenses 0. Fundraising expenses 0. Total expenses 274,961.